Erlotinib in the first-line treatment of non-small-cell lung cancer

By D'Arcangelo Manolo   Cappuzzo Federico  

Expert Review of Anticancer Therapy, Vol. 13, Iss. 5, 2013-05 ,pp. : 523-533

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxicity and Cell Death Mechanisms Induced by a Novel Bisnaphthalimidopropyl Derivative against the NCI-H460 non-small Lung Cancer Cell Line

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 13, Iss. 3, 2013-03 ,pp. : 414-421

Bentham Science Publishers

Access to resources Recommend Favorite

Luteolin exerts an anticancer effect on NCI-H460 human non-small cell lung cancer cells through the induction of Sirt1-mediated apoptosis

By Ma Liping   Peng Hongjun   Li Kunsheng   Zhao Runrun   Li Li   Yu Yilong   Wang Xiaoming   Han Zhifeng  

Molecular Medicine Reports, Vol. 12, Iss. 3, 2015-09 ,pp. : 4196-4202

Spandidos Publications

Access to resources Recommend Favorite

Induction of DNA damage by deguelin is mediated through reducing DNA repair genes in human non-small cell lung cancer NCI-H460 cells

By                    

Oncology Reports, Vol. 27, Iss. 4, 2012-01 ,pp. : 959-964

Spandidos Publications

Access to resources Recommend Favorite

Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 14, Iss. 5, 2014-06 ,pp. : 646-650

Bentham Science Publishers

Access to resources Recommend Favorite